{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T16:28:47Z","timestamp":1789921727466,"version":"4.0.1"},"reference-count":35,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Immunology"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.humimm.2018.02.003","type":"journal-article","created":{"date-parts":[[2018,2,15]],"date-time":"2018-02-15T13:15:42Z","timestamp":1518700542000},"page":"213-217","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["IL12B ,  IL23A ,  IL23R  and  HLA-C*06  genetic variants in psoriasis susceptibility and response to treatment"],"prefix":"10.1016","volume":"79","author":[{"given":"Adriana","family":"Bojko","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roksana","family":"Ostasz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Bia\u0142ecka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Klimowicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damian","family":"Malinowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Budawski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Bojko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marek","family":"Dro\u017adzik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4293-7788","authenticated-orcid":false,"given":"Mateusz","family":"Kurzawski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.humimm.2018.02.003_b0005","doi-asserted-by":"crossref","first-page":"J314","DOI":"10.1016\/j.jaut.2009.12.001","article-title":"Geoepidemiology and environmental factors of psoriasis and psoriatic arthritis","volume":"34","author":"Chandran","year":"2010","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.humimm.2018.02.003_b0010","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jaut.2015.07.008","article-title":"The immunogenetics of Psoriasis: a comprehensive review","volume":"64","author":"Harden","year":"2015","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.humimm.2018.02.003_b0015","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1365-2249.2004.00600.x","article-title":"Peripheral blood T cell responses to keratin peptides that share sequences with streptococcal M proteins are largely restricted to skin-homing CD8(+) T cells","volume":"138","author":"Johnston","year":"2004","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.humimm.2018.02.003_b0020","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.molimm.2014.12.014","article-title":"Genetic and epigenetic basis of psoriasis pathogenesis","volume":"64","author":"Chandra","year":"2015","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.humimm.2018.02.003_b0025","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1086\/511051","article-title":"A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes","volume":"80","author":"Cargill","year":"2007","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.humimm.2018.02.003_b0030","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1080\/1744666X.2017.1292137","article-title":"The role of IL 23 in the treatment of psoriasis","volume":"13","author":"Puig","year":"2017","journal-title":"Expert Rev. Clin. Immunol."},{"key":"10.1016\/j.humimm.2018.02.003_b0035","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/nature14175","article-title":"Clinical improvement in psoriasis with specific targeting of interleukin-23","volume":"521","author":"Kopp","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.humimm.2018.02.003_b0040","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1016\/S0140-6736(08)60726-6","article-title":"Efficacy and safety of ustekinumab, a human interleukin-12\/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 2)","volume":"371","author":"Papp","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.humimm.2018.02.003_b0045","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1111\/bjd.15005","article-title":"Polymorphisms in CD84, IL12B and TNFAIP3 are associated with response to biologics in patients with psoriasis","volume":"176","author":"van den Reek","year":"2017","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.humimm.2018.02.003_b0050","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1159\/000441719","article-title":"IL12B (p40) gene polymorphisms contribute to ustekinumab response prediction in psoriasis","volume":"232","author":"Galluzzo","year":"2016","journal-title":"Dermatology"},{"key":"10.1016\/j.humimm.2018.02.003_b0055","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1111\/bjd.12425","article-title":"The relationship between tumour necrosis factor (TNF)-alpha promoter and IL12B\/IL-23R genes polymorphisms and the efficacy of anti-TNF-alpha therapy in psoriasis: a case-control study","volume":"169","author":"Gallo","year":"2013","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.humimm.2018.02.003_b0060","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/exd.12577","article-title":"IL6 -174G>C polymorphism is associated with an increased risk of psoriasis but not response to treatment","volume":"24","author":"Bialecka","year":"2015","journal-title":"Exp. Dermatol."},{"issue":"Suppl 4","key":"10.1016\/j.humimm.2018.02.003_b0065","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1468-3083.2011.04059.x","article-title":"In touch with psoriasis: topical treatments and current guidelines","volume":"25","author":"Murphy","year":"2011","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"10.1016\/j.humimm.2018.02.003_b0070","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/jid.2008.233","article-title":"Genetic variants of the IL-23R pathway: association with psoriatic arthritis and psoriasis vulgaris, but no specific risk factor for arthritis","volume":"129","author":"Huffmeier","year":"2009","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.humimm.2018.02.003_b0075","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1086\/319501","article-title":"A new statistical method for haplotype reconstruction from population data","volume":"68","author":"Stephens","year":"2001","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.humimm.2018.02.003_b0080","doi-asserted-by":"crossref","first-page":"979258","DOI":"10.1155\/2009\/979258","article-title":"Cytokines and cytokine profiles in human autoimmune diseases and animal models of autoimmunity","volume":"2009","author":"Kunz","year":"2009","journal-title":"Mediators Inflamm."},{"key":"10.1016\/j.humimm.2018.02.003_b0085","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0923-1811(02)00072-5","article-title":"Interleukin-12 p40 gene (IL12B) 3'-untranslated region polymorphism is associated with susceptibility to atopic dermatitis and psoriasis vulgaris","volume":"30","author":"Tsunemi","year":"2002","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.humimm.2018.02.003_b0090","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/ng.311","article-title":"Genome-wide scan reveals association of psoriasis with IL-23 and NF-kappaB pathways","volume":"41","author":"Nair","year":"2009","journal-title":"Nat. Genet."},{"key":"10.1016\/j.humimm.2018.02.003_b0095","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1038\/ng.694","article-title":"A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1","volume":"42","author":"Strange","year":"2010","journal-title":"Nat. Genet."},{"key":"10.1016\/j.humimm.2018.02.003_b0100","doi-asserted-by":"crossref","first-page":"e0179348","DOI":"10.1371\/journal.pone.0179348","article-title":"The association between 38 previously reported polymorphisms and psoriasis in a Polish population: High predicative accuracy of a genetic risk score combining 16 loci","volume":"12","author":"Kisiel","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.humimm.2018.02.003_b0105","doi-asserted-by":"crossref","first-page":"726","DOI":"10.3109\/08820139.2013.810241","article-title":"Associations between interleukin-23R and interleukin-12B polymorphisms and psoriasis susceptibility: a meta-analysis","volume":"42","author":"Lee","year":"2013","journal-title":"Immunol. Invest."},{"key":"10.1016\/j.humimm.2018.02.003_b0110","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1007\/s00011-012-0509-8","article-title":"Association of IL23R polymorphisms with psoriasis and psoriatic arthritis: a meta-analysis","volume":"61","author":"Zhu","year":"2012","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.humimm.2018.02.003_b0115","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1007\/s00251-013-0721-x","article-title":"IL12B and IL23R gene SNPs in Japanese psoriasis","volume":"65","author":"Oka","year":"2013","journal-title":"Immunogenetics"},{"key":"10.1016\/j.humimm.2018.02.003_b0120","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1471-2350-10-8","article-title":"IL23R in the Swedish, Finnish, Hungarian and Italian populations: association with IBD and psoriasis, and linkage to celiac disease","volume":"10","author":"Einarsdottir","year":"2009","journal-title":"BMC Med. Genet."},{"key":"10.1016\/j.humimm.2018.02.003_b0125","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jdermsci.2014.05.010","article-title":"Genetic variation at IL12B, IL23R and IL23A is associated with psoriasis severity, psoriatic arthritis and type 2 diabetes mellitus","volume":"75","author":"Eiris","year":"2014","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.humimm.2018.02.003_b0130","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.humimm.2015.10.006","article-title":"Investigation of association of the IL-12B and IL-23R genetic variations with psoriatic risk in a South Indian Tamil cohort","volume":"77","author":"Indhumathi","year":"2016","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.humimm.2018.02.003_b0135","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/iji.12127","article-title":"IL-23R gene polymorphism rs2201841 is associated with psoriatic arthritis","volume":"41","author":"Popadic","year":"2014","journal-title":"Int. J. Immunogenet."},{"key":"10.1016\/j.humimm.2018.02.003_b0140","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s00011-012-0566-z","article-title":"Difference of interleukin-23 receptor gene haplotype variants in ulcerative colitis compared to Crohn's disease and psoriasis","volume":"62","author":"Safrany","year":"2013","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.humimm.2018.02.003_b0145","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1136\/ard.2011.150102","article-title":"Confirmation of TNIP1 and IL23A as susceptibility loci for psoriatic arthritis","volume":"70","author":"Bowes","year":"2011","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.humimm.2018.02.003_b0150","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1046\/j.0022-202x.2001.01656.x","article-title":"HLA-Cw6-positive and HLA-Cw6-negative patients with Psoriasis vulgaris have distinct clinical features","volume":"118","author":"Gudjonsson","year":"2002","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.humimm.2018.02.003_b0155","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1111\/ced.13100","article-title":"HLA-Cw6-positive patients with psoriasis show improved response to methotrexate treatment","volume":"42","author":"West","year":"2017","journal-title":"Clin. Exp. Dermatol."},{"key":"10.1016\/j.humimm.2018.02.003_b0160","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1111\/bjd.15387","article-title":"Role of the HLA-C*06 allele in clinical response to ustekinumab: evidence from real life in a large cohort of European patients","volume":"177","author":"Talamonti","year":"2017","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.humimm.2018.02.003_b0165","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1016\/j.jid.2016.06.631","article-title":"HLA-C*06:02 Allele and Response to IL-12\/23 Inhibition: Results from the Ustekinumab Phase 3 Psoriasis Program","volume":"136","author":"Li","year":"2016","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.humimm.2018.02.003_b0170","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/ng.310","article-title":"Psoriasis genome-wide association study identifies susceptibility variants within LCE gene cluster at 1q21","volume":"41","author":"Zhang","year":"2009","journal-title":"Nat. Genet."},{"key":"10.1016\/j.humimm.2018.02.003_b0175","doi-asserted-by":"crossref","first-page":"631","DOI":"10.2217\/pgs-2017-0014","article-title":"Polymorphisms associated with etanercept response in moderate-to-severe plaque psoriasis","volume":"18","author":"Ovejero-Benito","year":"2017","journal-title":"Pharmacogenomics"}],"container-title":["Human Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885918300417?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885918300417?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,6,26]],"date-time":"2018-06-26T12:44:01Z","timestamp":1530017041000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0198885918300417"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["S0198885918300417"],"URL":"https:\/\/doi.org\/10.1016\/j.humimm.2018.02.003","relation":{},"ISSN":["0198-8859"],"issn-type":[{"value":"0198-8859","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"IL12B, IL23A, IL23R and HLA-C*06 genetic variants in psoriasis susceptibility and response to treatment","name":"articletitle","label":"Article Title"},{"value":"Human Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humimm.2018.02.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}